On November 21, 2019 Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, reported its executives will participate in the following investor conferences (Press release, Akebia, NOV 21, 2019, View Source [SID1234551584]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Piper Jaffray 31st Annual Healthcare Conference on Tuesday, December 3, 2019, at 8:30 a.m. ET in New York City, New York.
Evercore ISI 2nd Annual HealthCONx Conference on Wednesday, December 4, 2019, at 3:50 p.m. ET in Boston, Massachusetts.
Where applicable, a live webcast and replay of Akebia’s presentation will be available on the Company’s website at www.akebia.com.